Comprehensive review of mechanisms of pathogenesis involved in Alzheimer's disease and potential therapeutic strategies

P Sharma, P Srivastava, A Seth, PN Tripathi… - Progress in …, 2019 - Elsevier
AD is a progressive neurodegenerative disorder and a leading cause of dementia in an
aging population worldwide. The enormous challenge which AD possesses to global …

Benzofuran and indole: promising scaffolds for drug development in Alzheimer's disease

D Goyal, A Kaur, B Goyal - ChemMedChem, 2018 - Wiley Online Library
Alzheimer's disease (AD) is a progressive neurodegenerative disease with no clinically
accepted treatment to cure or halt its progression. The Food and Drug Administration has …

Action mechanisms of curcumin in Alzheimer's disease and its brain targeted delivery

D Ege - Materials, 2021 - mdpi.com
AD is a chronic neurodegenerative disease. Many different signaling pathways, such as
Wnt/β-catenin, Notch, ROS/JNK, and PI3K/Akt/mTOR are involved in Alzheimer's disease …

Acetylcholinesterase and butyrylcholinesterase inhibitory activities of khellactone coumarin derivatives isolated from Peucedanum japonicum Thurnberg

JH Heo, BH Eom, HW Ryu, MG Kang, JE Park… - Scientific Reports, 2020 - nature.com
Cholinesterase (ChE) and monoamine oxidase (MAO) inhibitors have been attracted as
candidate treatments for Alzheimer's disease (AD). Fifteen khellactone-type coumarins from …

Design and development of benzyl piperazine linked 5-phenyl-1, 2, 4-triazole-3-thione conjugates as potential agents to combat Alzheimer's disease

PVR Kiran, DK Waiker, A Verma, P Saraf… - Bioorganic …, 2023 - Elsevier
Our present work demonstrates the molecular hybridization-assisted design, synthesis, and
biological evaluation of 22 benzylpiperazine-linked 1, 2, 4-triazole compounds (PD1-22) as …

Antibacterial activity and molecular docking studies of a selected series of hydroxy-3-arylcoumarins

MB Pisano, A Kumar, R Medda, G Gatto, R Pal, A Fais… - Molecules, 2019 - mdpi.com
Antibiotic resistance is one of the main public health concerns of this century. This resistance
is also associated with oxidative stress, which could contribute to the selection of resistant …

Phenoxyethyl piperidine/morpholine derivatives as PAS and CAS inhibitors of cholinesterases: insights for future drug design

Y Pourshojaei, A Abiri, K Eskandari, Z Haghighijoo… - Scientific reports, 2019 - nature.com
Acetylcholinesterase (AChE) catalyzes the conversion of Aβ peptide to its aggregated form
and the peripheral anionic site (PAS) of AChE is mainly involved in this phenomenon. Also …

Synthesis of 4-substituted benzyl-2-triazole-linked-tryptamine-paeonol derivatives and evaluation of their selective inhibitions against butyrylcholinesterase and …

JM Oh, Y Kang, JH Hwang, JH Park, WH Shin… - International Journal of …, 2022 - Elsevier
Cholinesterase (ChE) and monoamine oxidase (MAO) inhibitors are being used and
developed to treat Alzheimer's disease (AD), a major type of dementia patients. Fifteen 4 …

Novel Molecular Hybrids of N-Benzylpiperidine and 1,3,4-Oxadiazole as Multitargeted Therapeutics to Treat Alzheimer's Disease

P Sharma, A Tripathi, PN Tripathi… - ACS chemical …, 2019 - ACS Publications
Multitargeted hybrids of N-benzylpiperidine and substituted 5-phenyl-1, 3, 4-oxadiazoles
were designed, synthesized, and evaluated against Alzheimer's disease (AD). Tested …

Neuroprotective effect of terpenoids recovered from olive oil by-products

ZJ Suárez Montenegro, G Álvarez-Rivera… - Foods, 2021 - mdpi.com
The neuroprotective potential of 32 natural extracts obtained from olive oil by-products was
investigated. The online coupling of supercritical fluid extraction (SFE) and dynamic …